121 related articles for article (PubMed ID: 23092347)
1. MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options.
Fassan M; Baffa R; Kiss A; Zaninotto G; Rugge M
Curr Pharm Des; 2013; 19(7):1236-41. PubMed ID: 23092347
[TBL] [Abstract][Full Text] [Related]
2. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer.
Hemmatzadeh M; Mohammadi H; Karimi M; Musavishenas MH; Baradaran B
Biomed Pharmacother; 2016 Aug; 82():509-19. PubMed ID: 27470391
[TBL] [Abstract][Full Text] [Related]
3. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer.
Kestens C; Siersema PD; van Baal JW
World J Gastroenterol; 2016 Jan; 22(1):1-7. PubMed ID: 26755856
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets.
Mei LL; Qiu YT; Zhang B; Shi ZZ
Cancer Biomark; 2017; 19(1):1-9. PubMed ID: 28269750
[TBL] [Abstract][Full Text] [Related]
5. The role of microRNA in esophageal squamous cell carcinoma.
Harada K; Baba Y; Ishimoto T; Shigaki H; Kosumi K; Yoshida N; Watanabe M; Baba H
J Gastroenterol; 2016 Jun; 51(6):520-30. PubMed ID: 26794004
[TBL] [Abstract][Full Text] [Related]
6. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
[TBL] [Abstract][Full Text] [Related]
7. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Ishibashi O; Akagi I; Ogawa Y; Inui T
Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression in esophageal squamous cell carcinoma: Novel diagnostic and prognostic biomarkers.
Wang Y; Zhang J; Zhao W; Wang D; Ma W; Shang S; Feng C; Yu H
Mol Med Rep; 2017 Jun; 15(6):3833-3839. PubMed ID: 28440443
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response.
Odenthal M; Bollschweiler E; Grimminger PP; Schröder W; Brabender J; Drebber U; Hölscher AH; Metzger R; Vallböhmer D
Int J Cancer; 2013 Nov; 133(10):2454-63. PubMed ID: 23649428
[TBL] [Abstract][Full Text] [Related]
10. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
11. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
12. Computational analysis reveals microRNA-mRNA regulatory network in esophageal squamous cell carcinoma.
Zhao J; Zhang BC; Yu LF; Wang WX; Zhao Y; Rao ZG
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):834-838. PubMed ID: 27924512
[TBL] [Abstract][Full Text] [Related]
13. Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma.
Sugihara H; Ishimoto T; Miyake K; Izumi D; Baba Y; Yoshida N; Watanabe M; Baba H
Int J Mol Sci; 2015 Nov; 16(11):27824-34. PubMed ID: 26610479
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.
Zhang H; Shi X; Chang W; Li Y; Wang L; Wang L
Mol Med Rep; 2018 Feb; 17(2):2251-2256. PubMed ID: 29207103
[TBL] [Abstract][Full Text] [Related]
15. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma.
Jin YY; Chen QJ; Wei Y; Wang YL; Wang ZW; Xu K; He Y; Ma HB
J Radiat Res; 2016 Sep; 57(5):468-476. PubMed ID: 27422937
[TBL] [Abstract][Full Text] [Related]
18. The global expression profiling in esophageal squamous cell carcinoma.
Dai F; Mei L; Meng S; Ma Z; Guo W; Zhou J; Zhang J
Genomics; 2017 Jul; 109(3-4):241-250. PubMed ID: 28442363
[TBL] [Abstract][Full Text] [Related]
19. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors.
Yamamoto S; Inoue J; Kawano T; Kozaki K; Omura K; Inazawa J
Mol Cancer Res; 2014 Jan; 12(1):58-68. PubMed ID: 24307696
[TBL] [Abstract][Full Text] [Related]
20. An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma.
Yang Y; Li D; Yang Y; Jiang G
Mol Med Rep; 2015 Jul; 12(1):945-52. PubMed ID: 25823933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]